Materials and methods for tissue regeneration
The invention provides materials presenting a biologically active matrix comprising a physiological fibrillar fibronectin network, such as implantable constructs, and their use for modulating cell behaviour and fate, including cell growth, proliferation and/or differentiation, such as for promoting tissue regeneration, for example, bone regeneration or vascularization. Also provided are constructs presenting a biologically active matrix comprising a physiological fibrillar fibronectin network for sustaining growth of stem cells or maintaining stem cells (maintaining stemness).
1. An implantable construct comprising:
(a) a biocompatible substrate having a first surface, wherein the biocompatible substrate is selected from a synthetic polymer, a ceramic, a metal, an alloy and composites thereof;
(b) a material surface comprising an alkyl acrylate polymer deposited on said first surface, wherein the alkyl acrylate polymer is capable of supporting the formation of a physiological fibrillar network of FN adsorbed on its surface;
(c) fibronectin (FN) adsorbed on said material surface, wherein the FN forms a physiological fibrillar network of FN presenting colocalized growth factor binding domains and integrin binding domains; and
(d) a growth factor (GF) adsorbed on said FN, wherein said growth factor is capable of binding FNIII 12-14 .
2. The implantable construct of claim 1 , wherein the FN and GF together provide a biologically active matrix assembled on the material surface.
3. The implantable construct of claim 1 , wherein the construct is cell-free.
4. The implantable construct of claim 1 , wherein the alkyl acrylate polymer is:
(i) a member of the group of polymers having the formula —(C—C—COO(CH 2 ) x CH 3 )r, where x=1, 3, or 5;
(ii) poly(ethyl acrylate) (PEA);
(iii) a copolymer or blend comprising (1) an alkyl acrylate polymer capable of supporting the formation of a physiological fibrillar network of FN upon adsorption on its surface and (2) an alkyl acrylate polymer which alone is not capable of supporting the formation of a physiological fibrillar network of FN adsorbed on its surface, wherein the amount of (1) is about 50% or about 70%; or
(iv) PEA/PMA (70%/30%) or PEA/PMA (50%:50%).
5. The implantable construct of claim 1 , wherein the alkyl acrylate polymer surface is deposited as a thin (sub micron) layer surface on the substrate.
6. The implantable construct of claim 1 , wherein the FN is isolated human FN from plasma.
7. The implantable construct of claim 1 , wherein a growth factor is:
(i) BMP, VEGF, PDGF, TGF, FGF, IGF, HGF, BDNF or a neurotrophic GF; or
(ii) a recombinant human GF.
8. The implantable construct of claim 1 , wherein the construct comprises one or more further ECM components selected from vitronectin (VN), collagen IV and laminin.
9. A method of promoting tissue regeneration or growth comprising locating an implantable construct of claim 1 at a site of injury or disease.
10. A method of promoting bone regeneration, optionally in treating critical size bone defects after trauma or cancer, or promoting bone growth, optionally for spinal fusion, comprising locating an implantable construct of claim 1 at a site of injury or disease.
11. A method of treating bone damage, optionally bone fracture or a critical size bone defect, comprising locating an implantable construct of claim 1 at a site of bone damage, optionally a site of bone fracture or a critical size bone defect.
12. A method of promoting vascularization in a subject in need of vascularization, optionally as a result of injury or disease, comprising locating an implantable construct of claim 1 at a site of tissue damage, optionally from injury or disease.
13. A method of wound healing or treating a wound, comprising locating an implantable construct of claim 1 at a site of tissue damage.
14. A method of preparing an implantable construct according to claim 1 , comprising the steps of:
(a) depositing an alkyl acrylate polymer on a first surface of a biocompatible substrate to form a material surface wherein the biocompatible substrate is selected from a synthetic polymer, a ceramic, a metal, an alloy and composites thereof and further, wherein the alkyl acrylate polymer is capable of supporting the formation of a physiological fibrillar network of FN adsorbed on its surface; and
(b) applying fibronectin and a growth factor to said material surface to form a biologically active matrix, wherein said growth factor is capable of binding FNIII 12-14 ,
wherein the FN forms a physiological fibrillar network of FN presenting colocalized growth factor binding domains and integrin binding domains;
or the steps of:
(a) providing a biocompatible substrate having a first surface, wherein the biocompatible substrate is selected from a synthetic polymer, a ceramic, a metal, an alloy and composites thereof;
(b) depositing an alkyl acrylate polymer on said first surface to form a material surface; and
(c) applying fibronectin and a growth factor to said material surface to form a biologically active matrix,
wherein the FN forms physiological fibrillar network of FN presenting colocalized growth factor binding domains and integrin binding domains.
15. A kit comprising an implantable construct of claim 1 and instructions for using the kit.
16. A kit for preparing an implantable construct according to claim 1 comprising:
(a) a biocompatible substrate having a first surface and a material surface comprising an alkyl acrylate polymer deposited on said first surface, wherein the biocompatible substrate is selected from a synthetic polymer, a ceramic, a metal, an alloy and composites thereof and further wherein the alkyl acrylate polymer is capable of supporting the formation of a physiological fibrillar network of FN adsorbed on its surface; and
(b) fibronectin (FN) and a growth factor (GF) capable of forming a biologically active matrix when applied to said material surface, wherein said growth factor is capable of binding FNIII 12-14 ; and
(c) instructions for adsorbing the fibronectin (FN) and a growth factor (GF) onto the material surface to form a biologically active matrix wherein the FN forms a physiological fibrillar network of FN presenting colocalized growth factor binding domains and integrin binding domains, thus forming an implantable construct.
17. A method of sustaining growth of stem cells or maintaining stem cells (maintaining stemness) comprising contacting a construct comprising:
a biocompatible substrate having a first surface, wherein the biocompatible substrate is selected from a synthetic polymer, a ceramic, a metal, an alloy and composites thereof, a material surface comprising an alkyl acrylate polymer deposited on said first surface, wherein the alkyl acrylate polymer is capable of supporting the formation of a physiological fibrillar network of FN adsorbed on its surface, fibronectin (FN) adsorbed on said material surface, wherein the FN forms a physiological fibrillar network of FN presenting colocalized growth factor binding domains and integrin binding domains, and a growth factor (GF) adsorbed on said FN, wherein said growth factor is capable of binding FNIII 12-14 ,
with a stem cell under conditions capable of supporting stem cell viability or growth.
18. The method of claim 17 , wherein the construct is cell-free prior to contacting with the stem cell.
19. The method of claim 17 , which is carried out in vitro.
20. A composition comprising a construct, said construct comprising a biocompatible substrate having a first surface, wherein the biocompatible substrate is selected from a synthetic polymer, a ceramic, a metal, an alloy and composites thereof, a material surface comprising an alkyl acrylate polymer deposited on said first surface, wherein the alkyl acrylate polymer is capable of supporting the formation of a physiological fibrillar network of FN adsorbed on its surface, fibronectin (FN) adsorbed on said material surface, wherein the FN forms a physiological fibrillar network of FN presenting colocalized growth factor binding domains and integrin binding domains, and a growth factor (GF) adsorbed on said FN, wherein said growth factor is capable of binding FNIII 12-14 ; and a murine mesenchymal stem cell (MSC).
21. The implantable construct of claim 7 , wherein the PDGF is PDGF-BB.
22. The implantable construct of claim 7 , wherein the TGF is TGF-β.
23. The implantable construct of claim 7 , wherein the FGF is FGF2.
24. The implantable construct of claim 7 , wherein the BMP is selected from BMP-2 and BMP-7.
25. The method of claim 17 , wherein the stem cell is a mesenchymal stem cell (MSC).
26. The method of claim 18 , wherein the stem cell is a mesenchymal stem cell (MSC).
27. The implantable construct of claim 1 wherein the synthetic polymer is selected from polyvinyl alcohol (PVA), oligo[poly[ethylene glycol) fumarate] (OPF), poly(glycolic acid) (PGA), poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), polyether ether ketone (PEEK) and polycaprolactone (PCL).
28. The implantable construct of claim 1 wherein the ceramic is selected from hydroxyl carbonate apatite (HCA), calcium phosphate, hydroxyapatite (HA), tricalcium phosphate, bioactive glasses, alumina, zirconia, graphite and graphene.
29. The implantable construct of claim 1 wherein the metal or alloy is selected from stainless steel, cobalt-chromium, titanium and titanium alloys.